Across TCGA pan-cancer cohorts, RN7SKP111 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RN7SKP111 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SKP111 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP111 expression acts as an unfavorable survival marker.
BLCA are the cancer types where RN7SKP111 RNA most reproducibly stratifies survival.